Arvinas, Inc. - stock earnings
ARVN Upcoming estimated earnings
| Date | Actual / Estimated EPS | Low Revenue | Actual / Estimated Revenue | High Revenue |
|---|---|---|---|---|
| April 30, 2024 BeforeMarket | -2.53 / -1.45 | - | - / 35.8 million | - |
ARVN Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -154.8 million USD | -43.1 million USD |
| 2023Q3 | -64.0 million USD | 34.6 million USD |
| 2023Q2 | -66.6 million USD | 54.5 million USD |
| 2023Q1 | -80.8 million USD | 32.5 million USD |
| 2022Q4 | -79.9 million USD | 38.0 million USD |
| 2022Q3 | -66.2 million USD | 30.3 million USD |
| 2022Q2 | -70.0 million USD | 31.3 million USD |
| 2022Q1 | -63.4 million USD | 24.2 million USD |
| 2021Q4 | -53.0 million USD | 26.3 million USD |
| 2021Q3 | -46.8 million USD | 9.3 million USD |
| 2021Q2 | -50.3 million USD | 5.5 million USD |
| 2021Q1 | -41.0 million USD | 5.5 million USD |
| 2020Q4 | -41.5 million USD | 2.2 million USD |
| 2020Q3 | -30.8 million USD | 7.6 million USD |
| 2020Q2 | -25.2 million USD | 5.7 million USD |
| 2020Q1 | -21.7 million USD | 6.2 million USD |
| 2019Q4 | -21.0 million USD | 4.9 million USD |
| 2019Q3 | -17.7 million USD | 30.1 million USD |
| 2019Q2 | -17.2 million USD | 4.0 million USD |
| 2019Q1 | -14.4 million USD | 4.0 million USD |
| 2018Q4 | -16.1 million USD | 3.4 million USD |
| 2018Q3 | -13.4 million USD | 3.4 million USD |
| 2018Q2 | -7.9 million USD | 3.4 million USD |
| 2018Q1 | -4.2 million USD | 4.1 million USD |
| 2017Q4 | -4.7 million USD | 2.6 million USD |
| 2017Q3 | -6.4 million USD | 1.7 million USD |
| 2017Q2 | -6.7 million USD | 1.7 million USD |
| 2017Q1 | -6.2 million USD | 1.7 million USD |
| 2016Q4 | -14.4 million USD | 6.7 million USD |
ARVN Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -367.3 million USD | 78.5 million USD |
| 2022 | -271.9 million USD | 131.4 million USD |
| 2021 | -183.2 million USD | 46.7 million USD |
| 2020 | -111.8 million USD | 21.8 million USD |
| 2019 | -62.1 million USD | 43.0 million USD |
| 2018 | -41.5 million USD | 14.3 million USD |
| 2017 | -24.0 million USD | 7.6 million USD |
| 2016 | -14.4 million USD | 6.7 million USD |
ARVN
Price: $32.43
52 week price:
Earnings Per Share: -6.62 USD
P/E Ratio: -9.50
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 476209
Market Capitalization: 2.3 billion